A Transparency Market Research report found the U.S. implantable medical devices market will experience significant growth in the next few years.
Here are five takeaways:
1. By 2018, the market is expected to hit $73.94 billion.
2. Zimmer, Stryker and Abbot Laboratories are key vendors in this expansive market.
3. Factors spurring market growth include more chronic diseases, a larger aging population, more healthcare expenditures and more purchasing power parity.
4. Implantable devices' escalating prices pose as barriers to market growth.
5. Within the market, the orthopedic implants segment is leading and is expected to have revenue hitting nearly $38.05 billion by 2018.
More device news:
Spinal Elements' interspinous process device receives FDA clearance: 5 observations
Ronda Stryker sells 12k company shares with value of $1.38M — 5 key points
Global orthopedic biomaterial market to reach $38.1B by 2020 — 8 highlights